Millennium Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.73M | Buy |
236,991
+219,943
| +1,290% | +$6.25M | ﹤0.01% | 1877 |
|
|
2025
Q1 | $503K | Sell |
17,048
-6,893
| -29% | -$203K | ﹤0.01% | 3289 |
|
|
2024
Q4 | $696K | Buy |
23,941
+5,405
| +29% | +$157K | ﹤0.01% | 3092 |
|
|
2024
Q3 | $851K | Sell |
18,536
-106,839
| -85% | -$4.91M | ﹤0.01% | 3012 |
|
|
2024
Q2 | $5.12M | Sell |
125,375
-43,216
| -26% | -$1.77M | ﹤0.01% | 1915 |
|
|
2024
Q1 | $4.3M | Sell |
168,591
-172,025
| -51% | -$4.39M | ﹤0.01% | 2080 |
|
|
2023
Q4 | $3.08M | Sell |
340,616
-399,880
| -54% | -$3.62M | ﹤0.01% | 2213 |
|
|
2023
Q3 | $4.72M | Buy |
740,496
+695,356
| +1,540% | +$4.44M | ﹤0.01% | 1913 |
|
|
2023
Q2 | $501K | Buy |
+45,140
| New | +$501K | ﹤0.01% | 3283 |
|
|
2023
Q1 | – | Sell |
-750,445
| Closed | -$16.7M | – | 4899 |
|
|
2022
Q4 | $16.7M | Buy |
750,445
+711,532
| +1,829% | +$15.8M | 0.01% | 1147 |
|
|
2022
Q3 | $635K | Buy |
+38,913
| New | +$635K | ﹤0.01% | 3667 |
|
|
2022
Q1 | – | Sell |
-19,053
| Closed | -$453K | – | 5568 |
|
|
2021
Q4 | $453K | Buy |
19,053
+3,693
| +24% | +$87.8K | ﹤0.01% | 4085 |
|
|
2021
Q3 | $378K | Buy |
15,360
+7,260
| +90% | +$179K | ﹤0.01% | 4371 |
|
|
2021
Q2 | $200K | Sell |
8,100
-84,996
| -91% | -$2.1M | ﹤0.01% | 4712 |
|
|
2021
Q1 | $2.03M | Sell |
93,096
-11,120
| -11% | -$242K | ﹤0.01% | 2800 |
|
|
2020
Q4 | $2.66M | Buy |
+104,216
| New | +$2.66M | ﹤0.01% | 2328 |
|
|
2020
Q3 | – | Sell |
-226,044
| Closed | -$6.39M | – | 3846 |
|
|
2020
Q2 | $6.39M | Buy |
+226,044
| New | +$6.39M | 0.01% | 1230 |
|